1084 (1084) Fair Value & Analysis

Consumer Defensive · Market cap HK$573M

1 1084 1084 · HK

PriceHK$0.6600

Fair ValueHK$0.1800

Upside-72.7%

Quality43/100

Evidence: Medium Range HK$0.1100 – HK$0.2300

Fair value as of: Jul 2, 2026

From 13 valuation models · updated today

Share price +1.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.5894 – HK$0.7368 · fair‑value band HK$0.1100 – HK$0.2300 · the HK$0.6600 price screens above the HK$0.1800 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1084 (1084) currently trades at HK$0.6600, while our model-based Fair Value estimate is HK$0.1800 — implying the stock looks roughly 72.7% overvalued today. We read business quality at 43/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1084 generated revenue of HK$905M at a net margin of 0.7%. Revenue declined 6.7% year over year. It earns a return on equity of 0.6%. Net debt stands at HK$485M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$905M

Revenue growth (YoY) -6.7%

Net margin 0.7%

Return on equity 0.6%

Free cash flow −HK$45.4M FY2025

P/E ratio 66.0

More key figures

Operating margin 8.1%

EPS (TTM) HK$-0.0100

Dividend yield 1.7%

EPS growth (YoY) -52.7%

Net debt HK$485M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1084 reported revenue of HK$904M in FY2025 versus HK$1.2B in FY2021, a compound −6.1%/yr. Reported net income was HK$6.6M in FY2025, compounding −49.8%/yr from FY2021.

Revenue −6.1%/yr

FY21 HK$1.2B

FY22 HK$1.6B

FY23 HK$1.2B

FY24 HK$989M

FY25 HK$904M

Net income −49.8%/yr

FY21 HK$104M

FY22 HK$199M

FY23 −HK$85.3M

FY24 HK$62.1M

FY25 HK$6.6M

Is 1084 fairly valued? → Check now

Similar stocks

6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Archer-Daniels-Midland Company ADM	$81.28	$38.31	-53%
Muyuan Foods Group 002714	¥35.06	¥49.23	+40%
Bunge Global SA BG	$128.21	$88.65	-31%
Tyson Foods, Inc TSN	$58.73	$34.80	-41%
Wens Foodstuff Group 300498	¥12.83	¥7.44	-42%
Mowi ASA MOWI	kr 204.00	kr 112.48	-45%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1084 (1084) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1800 versus a price of HK$0.6600 — about −73% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1084?

Our model-based fair value for 1084 is HK$0.1800 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.6600.

What is the quality score of 1084?

1084 has a Quality Score of 43/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1084 (1084)?

1084 reported trailing-twelve-month revenue of about HK$905M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1084?

The net profit margin of 1084 is about 0.7%, meaning it keeps roughly 0.7% of revenue as net income. Based on the latest reported figures.

Does 1084 pay a dividend?

1084 currently shows a dividend yield of about 1.67% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.